Antifungal effect of silver nanoparticles on dermatophytes

Journal of Microbiology and Biotechnology

Volumn 18, Issue 8, 2008, Pages 1482-1484

  Kim, Keuk Jun ^a   Sung, Woo Sang ^a   Moon, Seok Ki ^b   Choi, Jong Soo ^b   Kim, Jong Guk ^a   Lee, Dong Gun ^a  

^a Kyungpook National University   (South Korea)

^b Yeungnam University College of Medicine   (South Korea)

Author keywords

Antifungal effect; Candida species; Silver nanoparticles; Trichophyton mentagrophytes

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; METAL NANOPARTICLE; SILVER NANOPARTICLE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DERMATOPHYTE; DRUG EFFECT; DRUG RESEARCH; DRUG SYNTHESIS; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; MYCELIUM; MYCOSIS; NONHUMAN; SKIN INFECTION; TRICHOPHYTON MENTAGROPHYTES;

ANTIFUNGAL AGENTS; CANDIDA; DERMATOMYCOSES; HUMANS; METAL NANOPARTICLES; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; SILVER; TRICHOPHYTON;

ARTHRODERMA BENHAMIAE; ARTHRODERMATACEAE; CANDIDA; CANDIDA ALBICANS;

EID: 56749157611     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Baker, C., A. Pradhan, L. Pakstis, D. J. Pochan, and S. I. Shah. 2005. Synthesis and antibacterial properties of silver nanoparticles. J. Nanosci. Nanotechnol. 5: 244-249.
2. Boaz, A. and H. G. Marcelo. 1998. Adverse drug reactions of the new oral antifungal agents - terbinafine, fluconazole, and itraconazole. Int. J. Dermatol. 37: 410-415.
3. Brigger, I., C. Dubernet, and P. Couvreur. 2002. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54: 631-651.
4. Hartsel, S. and J. Bolard. 1996. Amphotericin B: New life for an old drug. Trends Pharmacol. Sci. 17: 445-449.
5. Jung, H. J., Y. B. Seu, and D. G. Lee. 2007. Candicidal action of resveratrol isolated from grapes on human pathogenic yeast C. albicans. J. Microbiol. Biotechnol. 17: 1324-1329.
6. Klasen, H. J. 2000. A historical review of the use of silver in the treatment of burns. Π Renewed interest for silver. Burns 26: 131-138.
7. Lee, B. U., S. H. Yun, J.-H. Ji, and G.-N. Bae. 2008. Inactivation of S. epidermidis, B. subtilis, and E. coli bacteria bioaerosols deposited on a filter utilizing airborne silver nanoparticles. J. Microbiol. Biotechnol. 18: 176-182.
8. Mclain, N., R. Ascanio, C. Baker, R. A. Strohaver, and J. W. Dolan. 2000. Undecylenic acid inhibits morphogenesis of Candida albicans. Antimicrob. Agents Chemother. 44: 2873-2875.
9. Melaiye, A., Z. Sun, K. Hindi, A. Milsted, D. Ely, D. H. Reneker, C. A. Tessier, and W. J. Youngs. 2005. Silver(I)-imidazole cyclophane gem-diol complexes encapsulated by electrospun tecophilic nanofibers: Formation of nanosilver particles and antimicrobial activity. J. Am. Chem. Soc. 127: 2285-2291.
10. Merisko-Liversidge, E., G. G. Liversidge, and E. R. Cooper. 2003. Nanosizing: A formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 18: 113-120.
11. Mirmirani, P., N. A. Hessol, T. A. Maurer, T. G. Berger, P. Nguyen, A. Khalsa, et al. 2001. Prevalence and predictors of skin disease in the Women's Interagency HIV Study (WIHS). J. Am. Acad. Dermatol. 44: 785-788.
12. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved standard, document M27-A, NCCLS, Wayne, PA.
13. National Committee for Clinical Laboratory Standards. 1998. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi: Proposed standard, document M-38P, NCCLS, Wayne, PA.
14. Russell, A. D. and W. B. Hugo. 1994. Antimicrobial activity and action of silver. Prog. Med. Chem. 31: 351-370.
15. Silver, S. 2003. Bacterial silver resistance: Molecular biology and uses and misuses of silver compounds. FEMS Microbiol. Rev. 27: 341-353.
16. Sondi, I. and B. Salopek-Sondi. 2004. Silver nanoparticles as antimicrobial agent: A case study on E. coli as a model for Gram-negative bacteria. J. Colloid Interface Sci. 275: 177-182.
17. Sung, W. S., H. J. Jung, I. -S. Lee, H. S. Kim, and D. G. Lee. 2006. Antimicrobial effect of furaneol against human pathogenic bacteria and fungi. J. Microbiol. Biotechnol. 16: 349-354.
18. Sung, W. S., I.-S. Lee, and D. G. Lee. 2007. Damage to the cytoplasmic membrane and cell death caused by lycopene in Candida albicans. J. Microbiol. Biotechnol. 17: 1797-1804.
19. Woodfolk, J. A. 2005. Allergy and dermatophytes. Clin. Microbiol. Rev. 18: 30-43.